AI assistant
ECHOIQ LIMITED — Capital/Financing Update 2017
May 30, 2017
64833_rns_2017-05-30_2f86eda1-cead-48f0-b990-847763dd0f76.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [241 x 66] intentionally omitted <==
ASX Announcement
31 May 2017
Expiry of Listed Options
Veriluma Limited (ASX: VRI , Veriluma or Company ) advises that the 44,354,509 listed options quoted on ASX under code VRIOB and exercisable at $0.05 expired at 5pm AEST on 30 May 2017.
The Company has received an application to exercise options over 27,400 fully paid ordinary shares. The shares will be issued and allotted subject to confirmation of receipt of cleared funds. An updated Appendix 3B will be released once the shares have been allotted.
Lisa Dadswell Company Secretary Veriluma Limited
For more information, please contact:
Elizabeth Whitelock Chief Executive Officer [email protected] +61 2 8039 0533
Peter Taylor Investor Relations [email protected] + 61 412 036 231
www.veriluma.com
About Veriluma and Prescriptive Analytics
Veriluma has developed and patented an advanced algorithm dealing in Prescriptive Analytics. Prescriptive Analytics is a form of advanced, forward-looking analytics, which provides assessments about future outcomes. Although most types of analytics aim to assist and improve in the decision-making process, only Prescriptive Analytics delivers a preferred course of action. Developed by a Commonwealth Research Centre for the Australian Defence Intelligence Organisation, which has been utilising Veriluma’s technology since 2013, Veriluma’s software assists decision makers with rapid and accurate assessments of terrorism and national security threats using its proprietary technology based on Prescriptive Analytics.
Developed in Defence, Veriluma’s software engine is now applicable across a broad range of industry.
In complex decision making situations, the ability to comprehensively manage incomplete or uncertain inputs is highly valuable for businesses, governments and individuals. ¹The Prescriptive Analytics software market is expected to reach US$1.1 billion in the next 3 years, with a 22% Compound Annual Growth Rate (CAGR) from 2016. Currently, 10% of organisations have some form of prescriptive analytics and this is expected to grow to 35% by 2020.
¹Source: Gartner Forecast Snapshot: Prescriptive Analytics, Worldwide, 2016; 5 February 2016